Ranee Mehra

Ranee Mehra

UNVERIFIED PROFILE

Are you Ranee Mehra?   Register this Author

Register author
Ranee Mehra

Ranee Mehra

Publications by authors named "Ranee Mehra"

Are you Ranee Mehra?   Register this Author

74Publications

2129Reads

17Profile Views

Liquid biopsy tracking of lung tumor evolutions over time.

Expert Rev Mol Diagn 2019 Dec 16;19(12):1099-1108. Epub 2019 Oct 16.

Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2020.1680287DOI Listing
December 2019

RET fusions in solid tumors.

Cancer Treat Rev 2019 Dec 30;81:101911. Epub 2019 Oct 30.

Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2019.101911DOI Listing
December 2019

Pembrolizumab for the treatment of head and neck squamous cell cancer.

Expert Opin Biol Ther 2019 Sep 19;19(9):879-885. Epub 2019 Jul 19.

b Department of Oncology, University of Maryland School of Medicine , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2019.1644315DOI Listing
September 2019

How I treat ALK-positive non-small cell lung cancer.

ESMO Open 2019 20;4(Suppl 2):e000524. Epub 2019 Jul 20.

University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2019-000524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677959PMC
July 2019

Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States.

Head Neck 2018 12 13;40(12):2612-2620. Epub 2018 Nov 13.

Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hed.25333
Publisher Site
http://dx.doi.org/10.1002/hed.25333DOI Listing
December 2018

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas.

J Immunother Cancer 2018 08 31;6(1):84. Epub 2018 Aug 31.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 401 N Broadway, 1550 Orleans St., CRB2 5M44, Baltimore, MD, 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-018-0395-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117944PMC
August 2018

Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC).

Cancers Head Neck 2018 4;3. Epub 2018 Jun 4.

2Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 201 N Broadway, Baltimore, MD USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s41199-018-0030-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460806PMC
June 2018

Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.

J Immunother Cancer 2017 16;5:40. Epub 2017 May 16.

Department of Medicine, Section of Endocrinology, Fox Chase Cancer Center, Philadelphia, PA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0245-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433051PMC
January 2018

Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification.

Ear Nose Throat J 2017 Jul;96(7):E12-E18

Department of Radiation Oncology, 333 Cottman Ave., Philadelphia, PA 19111-2497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/014556131709600703DOI Listing
July 2017

Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.

Head Neck 2017 03 8;39(3):E34-E39. Epub 2016 Nov 8.

Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439525PMC
March 2017

Early oral tongue cancer initially managed with surgery alone: Treatment of recurrence.

World J Otorhinolaryngol Head Neck Surg 2016 Dec 5;2(4):193-197. Epub 2016 May 5.

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wjorl.2016.03.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698535PMC
December 2016

The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.

Int J Radiat Oncol Biol Phys 2016 12 6;96(5):967-975. Epub 2016 Sep 6.

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.08.046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147736PMC
December 2016

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.

J Clin Oncol 2016 11 30;34(32):3838-3845. Epub 2016 Sep 30.

Laura Q.M. Chow, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Robert Haddad, Dana-Farber Cancer Institute, Boston, MA; Shilpa Gupta and Amit Mahipal, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Ranee Mehra, Fox Chase Cancer Center, Philadelphia, PA; Joseph Paul Eder and Barbara Burtness, Yale University Cancer Center, New Haven, CT; Hyunseok Kang, Johns Hopkins University, Baltimore, MD; Jared Weiss, Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, NC; Amy Meister, Marisa Dolled-Filhart, Kumudu Pathiraja, and Jonathan D. Cheng, Merck, Kenilworth, NJ; Tanguy Y. Seiwert, The University of Chicago, Chicago, IL; Makoto Tahara, National Cancer Center Hospital East, Kashiwa; Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan; Raanan Berger, Sheba Medical Center, Tel Hashomer; Ravit Geva, Sourasky Medical Center, Tel-Aviv, Israel; Se-Hoon Lee and Bhumsuk Keam, Seoul National University Hospital; Hyun Cheol Chung, Yonsei University College of Medicine, Seoul, Korea; and Chia-Chi Lin, National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1478DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804896PMC
November 2016

EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer.

Mol Cancer Ther 2016 10 9;15(10):2486-2497. Epub 2016 Aug 9.

Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Molecular and Cell Biology & Genetics Program, Drexel University College of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522587PMC
October 2016

Overview of Current Treatment Options and Investigational Targeted Therapies for Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Am J Clin Oncol 2016 08;39(4):396-406

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000283DOI Listing
August 2016

Impact of baseline patient-reported dysphagia on acute gastrostomy placement in patients with head and neck squamous cell carcinoma undergoing definitive radiation.

Head Neck 2016 04 31;38 Suppl 1:E1318-24. Epub 2015 Aug 31.

Department of Surgical Oncology, Fox Chase Cancer Center, Temple Head and Neck Institute, Temple University Health System, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24220DOI Listing
April 2016

HPV-negative head and neck squamous cell carcinomas: how can we use the tumor protein signature?

Biomark Med 2015 ;9(3):183-5

Fox Chase Cancer Center, Department of Medical Oncology, 333 Cottman Ave, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm.15.1DOI Listing
November 2015

Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer.

Oral Oncol 2015 Nov 5;51(11):1034-1040. Epub 2015 Oct 5.

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.09.001DOI Listing
November 2015

The efficacy of ceritinib in patients with ALK-positive non-small cell lung cancer.

Ther Adv Respir Dis 2015 Oct 30;9(5):236-41. Epub 2015 Jul 30.

Fox Chase Cancer Center, 333 Cottman Avenue Philadelphia, PA 19111, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753465815597834DOI Listing
October 2015

Targeting brain metastases in ALK-rearranged non-small-cell lung cancer.

Lancet Oncol 2015 Oct;16(13):e510-21

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00013-3DOI Listing
October 2015

Systemic therapy for squamous cell carcinoma of the head and neck.

Surg Oncol Clin N Am 2015 Jul;24(3):437-54

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2015.03.004DOI Listing
July 2015

Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.

Cancer 2015 Apr 9;121(8):1204-13. Epub 2014 Dec 9.

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29191DOI Listing
April 2015

Co-targeting ER and HER family receptors induces apoptosis in HER2-normal or overexpressing breast cancer models.

Anticancer Res 2015 Mar;35(3):1243-50

Departments of Internal Medicine (Section of Medical Oncology) and Pharmacology, and the Yale Cancer Center/Smilow Cancer Hospital, Yale University School of Medicine, New Haven, CT, U.S.A.

View Article

Download full-text PDF

Source
March 2015

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

J Clin Oncol 2014 Sep 21;32(25):2735-43. Epub 2014 Jul 21.

Ezra E.W. Cohen, Theodore G. Karrison, Masha Kocherginsky, Jeffrey Mueller, Robyn Egan, Tanguy Y. Seiwert, Victoria M. Villaflor, Daniel J. Haraf, and Everett E. Vokes, University of Chicago, Chicago; Bruce E. Brockstein, North Shore University Health System, Evanston; Mark B. Agulnik and Bharat B. Mittal, Northwestern University, Chicago, IL; Chao H. Huang, University of Kansas and Veterans Affairs Medical Center, Kansas City, KS; Furhan Yunus and Sandeep Samant, University of Tennessee, Memphis, TN; Luis E. Raez, University of Miami, Miami, FL; Ranee Mehra, Fox Chase Cancer Center, Philadelphia, PA; Priya Kumar and Frank Ondrey, University of Minnesota, Minneapolis, MN; and Patrice Marchand and Bettina Braegas, Nuvisan Oncology, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/07/18/JCO.2013.54
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.6309
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.6309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876357PMC
September 2014

Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer.

Cancer Chemother Pharmacol 2014 Sep 19;74(3):437-46. Epub 2014 Aug 19.

Fox Chase Cancer Center, 393 Cottman Avenue, Philadelphia, PA, 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2517-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627646PMC
September 2014

Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer.

Cancer 2014 Mar 18;120(6):840-7. Epub 2013 Dec 18.

Department of Surgical Oncology, Head and Neck Surgery Section, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951722PMC
March 2014

Ceritinib in ALK-rearranged non-small-cell lung cancer.

N Engl J Med 2014 Mar;370(13):1189-97

From Massachusetts General Hospital, Boston (A.T.S., J.A.E.); Seoul National University Hospital, Seoul, South Korea (D.-W.K.); Fox Chase Cancer Center, Philadelphia (R.M.); National Cancer Center and Genome Institute of Singapore, Singapore (D.S.W.T.); Vall d'Hebron University, Barcelona (E.F.); University of Washington, Seattle (L.Q.M.C.); University of Colorado, Denver (D.R.C.); University Hospital KU Leuven, Leuven, Belgium (J.V.); Huntsman Cancer Institute, Salt Lake City (S.S.); Istituto Europeo di Oncologia (T.D.P.) and Istituto di Ricovero e Cura a Carattere Scientifico Istituto Clinico Humanitas (A.S.) - both in Milan; Memorial Sloan-Kettering Cancer Center, New York (G.J.R.); Peter MacCallum Cancer Center, Melbourne, VIC, Australia (B.J.S.); Center for Integrated Oncology, University Hospital Cologne, Cologne (J.W.), Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg, German Center for Lung Research (M.T.), and German Cancer Consortium (M.S.), Heidelberg, and University Duisburg-Essen, Essen (M.S.) - all in Germany; Princess Margaret Cancer Center, Toronto (G.L.); and Novartis Institutes for BioMedical Research, Cambridge, MA (Y.Y.L., M.G., A.L.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1311107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079055PMC
March 2014

Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.

Cancer Control 2014 Jan;21(1):57-62

Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481402100108DOI Listing
January 2014

Aurora kinases in head and neck cancer.

Lancet Oncol 2013 Sep;14(10):e425-35

Program in Developmental Therapeutics, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70128-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139969PMC
September 2013

False-positive scalp activity in 131I imaging associated with hair coloring.

J Nucl Med Technol 2013 Mar 4;41(1):43-5. Epub 2013 Feb 4.

Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnmt.112.117416DOI Listing
March 2013

Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns.

Head Neck 2013 Feb 2;35(2):160-4. Epub 2012 Feb 2.

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.22929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037756PMC
February 2013

Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling".

Sci Signal 2012 Dec 11;5(254):lc5. Epub 2012 Dec 11.

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.2003734DOI Listing
December 2012

Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.

Semin Radiat Oncol 2012 Jul;22(3):194-7

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2012.03.003DOI Listing
July 2012

Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer.

Drug Resist Updat 2011 Dec 14;14(6):260-79. Epub 2011 Sep 14.

Program in Developmental Therapeutics, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drup.2011.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195944PMC
December 2011

Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.

Head Neck 2011 Oct 10;33(10):1433-40. Epub 2010 Nov 10.

Department of Otolaryngology, Temple University Hospital, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.21615DOI Listing
October 2011

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer.

Biologics 2010 Aug 9;4:173-85. Epub 2010 Aug 9.

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921255PMC
http://dx.doi.org/10.2147/btt.s3050DOI Listing
August 2010

Current issues in adjuvant chemotherapy for resected, stage IB non-small-cell lung cancer.

Future Oncol 2009 Feb;5(1):19-22

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/14796694.5.1.19
Publisher Site
http://dx.doi.org/10.2217/14796694.5.1.19DOI Listing
February 2009

New agents in the treatment for malignancies of the salivary and thyroid glands.

Hematol Oncol Clin North Am 2008 Dec;22(6):1279-95, xi

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2008.08.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659655PMC
December 2008

The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck.

Clin Adv Hematol Oncol 2008 Oct;6(10):742-50

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745918PMC
October 2008

EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.

Curr Oncol Rep 2008 Mar;10(2):176-84

Department of Human Oncology, University of Wisconsin School of Medicine, 600 Highland Avenue K4/336, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-008-0027-6DOI Listing
March 2008

DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD) IN GI MALIGNANCIES: EXPERIENCE OF 4-YEARS.

Pak J Med Sci 2007 ;23(6):832-839

Yale University School of Medicine, New Haven, CT Athens Medical School, Sotiria General Hospital, Athens, Greece.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563423PMC
January 2007

Antibody therapy for early-stage breast cancer: trastuzumab adjuvant and neoadjuvant trials.

Expert Opin Biol Ther 2006 Sep;6(9):951-62

Fox Chase Cancer Center, Division of Medical Sciences, Department of Medical Oncology, 333 Cottman Ave, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14712598.6.9.951
Publisher Site
http://dx.doi.org/10.1517/14712598.6.9.951DOI Listing
September 2006

Incidence and management of bevacizumab-related toxicities in colorectal cancer.

Expert Opin Drug Saf 2006 Jul;5(4):553-66

Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.5.4.553DOI Listing
July 2006

The second annual symposium on the future of lung cancer: a translational focus. 11-12 November 2005, Washington D.C., USA.

Authors:
Ranee Mehra

Expert Opin Ther Targets 2006 Jun;10(3):475-80

Yale University, Cancer Center, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.10.3.475DOI Listing
June 2006

Severe irinotecan-induced toxicities in a patient with uridine diphosphate glucuronosyltransferase 1A1 polymorphism.

Clin Colorectal Cancer 2005 May;5(1):61-4

Department of Medical Oncology, Yale University Cancer Center, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/ccc.2005.n.018DOI Listing
May 2005